Solventum Corp reported $1.27B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Cencora USD -339.7M 1.03B Sep/2025
Dexcom USD 267.3M 16.5M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
West Pharmaceutical Services USD 132.1M 7.9M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025